Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
about
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and ResistanceInhibitory Effect of 2'-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon CellsMutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.General Catalytic Deficiency of Hepatitis C Virus RNA Polymerase with an S282T Mutation and Mutually Exclusive Resistance towards 2'-Modified Nucleotide AnaloguesHepatitis C Virus (HCV) NS5B Nonnucleoside Inhibitors Specifically Block Single-Stranded Viral RNA Synthesis Catalyzed by HCV Replication Complexes In VitroPyrophosphorolytic Excision of Nonobligate Chain Terminators by Hepatitis C Virus NS5B PolymeraseInhibition of Hepatitis C Virus (HCV) RNA Polymerase by DNA Aptamers: Mechanism of Inhibition of In Vitro RNA Synthesis and Effect on HCV-Infected CellsA Locking Mechanism Regulates RNA Synthesis and Host Protein Interaction by the Hepatitis C Virus PolymeraseResistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine InhibitorMechanism of Hepatitis C Virus RNA Polymerase Inhibition with Dihydroxypyrimidines1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C VirusCharacterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase.High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitorsInhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.Current and emerging therapeutic approaches to hepatitis C infection.Challenges and successes in developing new therapies for hepatitis C.Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.Antiviral therapy for hepatitis C virus: beyond the standard of care.Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.Molecular modeling study on the drug resistance mechanism of NS5B polymerase to TMC647055.
P2860
Q26783056-B4D4DF32-D5C3-4EA6-88F5-B3A6AB806EEAQ27469482-55D52EA9-4754-41FE-9A1B-A85397CD4436Q27472610-D3593EBE-44F0-495D-B2B8-B2A0B83C048BQ27477760-6E734F21-0125-47A0-B005-44B3A380D561Q27478063-25EDA9D2-75D4-4F92-8A77-449E8B4254C8Q27480921-ABE0ED23-4CCE-4030-ACC1-14EFA3C2C119Q27486247-87297E90-08E7-45A6-849F-89898190829CQ27486419-0BF2AF5B-99A3-4EA5-BBF3-3EEA8CC0DDA7Q27486873-8C013859-E79E-412F-B336-348E619457CFQ27490954-2BD59229-82F7-4493-BC06-4C81B0B976A9Q27490956-AF5072D1-18CD-4A7E-8800-6F563A4A6C62Q33793620-7D5FE8CB-8D8F-4CE7-A124-0C5662D81E47Q33948876-CC78825B-8884-4779-BC7A-8A5344C0D2F8Q35260330-B22DB874-7F68-4107-A5D8-6E7655911A97Q35917244-5E52C71C-DDFE-4D1E-B2A0-F9AD6BB7D272Q36233823-D5A81B0C-35C6-47C9-9322-FFD1E79A64C9Q36509228-09E1FBB4-5739-47E2-B6C2-87C1B28A3085Q37945201-EC201386-C3A2-4A8A-B402-B44A4235FF0CQ38034733-72ADF879-2D5B-4379-BD51-1C596948ADBAQ39968924-99B92FBC-B30D-4871-80B5-F33D3AEEE0E6Q40604363-B7F36EB7-BAA3-4FBB-A425-8DC3E3A4A293Q40695351-370BC77C-A545-4018-A9B9-0A8C48D51E5EQ40730284-75E780AB-6B2C-4034-8AF8-416A1FA8FA0AQ40935601-85E4E3B1-9B76-4532-B037-D150B08E9BDD
P2860
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@en
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@nl
type
label
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@en
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@nl
prefLabel
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@en
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
@nl
P2093
P2860
P356
P1476
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives
@en
P2093
C Cheng Kao
Dashyant Dhanak
Lester L Gutshall
Michael G Darcy
Richard R Gontarek
Robert T Sarisky
Tammy T Nguyen
Victor K Johnston
P2860
P304
16602-16607
P356
10.1074/JBC.M210891200
P407
P577
2003-01-27T00:00:00Z